Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer

Japanese Journal of Radiology

Volumn 30, Issue 4, 2012, Pages 296-309

  Sugiyama, Yukiko ^a   Kadoya, Masumi ^a   Hamano, Hideaki ^a   Fujinaga, Yasunari ^a   Ueda, Kazuhiko ^a   Kawa, Shigeyuki ^b   Kurozumi, Masahiro ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

Author keywords

Autoimmune pancreatitis; Magnetic resonance imaging; Pancreas; Pancreatic cancer; Pancreatitis

Indexed keywords

FAT;

ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREAS DUCT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84863226320     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-011-0047-2     Document Type: Article

References (49)

1. Toki F, Kozu T, Oi I, Nakasato T, Suzuki M, Hanyu F. An unusual type of chronic pancreatitis showing diffuse irregular narrowing of the entire main pancreatic duct on ERCP-a report of four cases. Endoscopy. 1992;24:640 (abstract).
2. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561-8.
3. Ito T, Nakano I, Koyanagi S, Miyahara T, Migita Y, Ogoshi K, et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci. 1997;42:1458-68. (Pubitemid 27339364)
4. Wakabayashi T, Motoo Y, Kojima Y, Makino H, Sawabu N. Chronic pancreatitis with diffuse irregular narrowing of the main pancreatic duct. Dig Dis Sci. 1998;43:2415-25. (Pubitemid 28531313)
5. Horiuchi A, Kawa S, Akamatsu T, Aoki Y, Mukawa K, Furuya N, et al. Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: a case report and review of the Japanese literature. Am J Gastroenterol. 1998;93:260-3. (Pubitemid 29063980)
6. Erkelens GW, Vleggaar FP, Lesterhuis W, van Buuren HR, van der Werf SD. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet. 1999;354:43-4. (Pubitemid 29304304)
7. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-8. (Pubitemid 32204991)
8. Hamano H, Kawa S, Ochi Y, Unno H, Shiba N, Wajiki M, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403-4. (Pubitemid 34442382)
9. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut. 2002; 51:1-4. (Pubitemid 34717730)
10. Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, et al. Autoimmune pancreatitis: imaging features. Radiology. 2004;233:345-52. (Pubitemid 39423790)
11. Yang DH, Kim KW, Kim TK, Park SH, Kim SH, Kim MH, et al. Autoimmune pancreatitis: radiologic findings in 20 patients. Abdom Imaging. 2006;31:94-102. (Pubitemid 43081645)
12. Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010-6 (quiz 934). (Pubitemid 44118845)
13. Irie H, Honda H, Baba S, Kuroiwa T, Yoshimitsu K, Tajima T, et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol. 1998;170:1323-7.
14. Furukawa N, Muranaka T, Yasumori K, Matsubayashi R, Hayashida K, Arita Y. Autoimmune pancreatitis: radiologic findings in three histologically proven cases. J Comput Assist Tomogr. 1998;22:880-3. (Pubitemid 28533569)
15. Servais A, Pestieau SR, Detry O, Honore P, Belaiche J, Boniver J, et al. Autoimmune pancreatitis mimicking cancer of the head of pancreas: report of two cases. Acta Gastroenterol Belg. 2001;64: 227-30. (Pubitemid 32635416)
16. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, Abraham SC, Yeo CJ, Lillemoe KD, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg. 2003; 237:853-8 (discussion 8-9).
17. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Kamata N. Clinical difficulties in the differentiation ofautoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol. 2003;98:2694-9. (Pubitemid 38020110)
18. Yadav D, Notahara K, Smyrk TC, Clain JE, Pearson RK, Farnell MB, et al. Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection. Clin Gastroenterol Hepatol. 2003;1:129-35. (Pubitemid 37248083)
19. Abraham SC, Wilentz RE, Yeo CJ, Sohn TA, Cameron JL, Boitnott JK, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am J Surg Pathol. 2003;27:110-20. (Pubitemid 36014904)
20. Mizuno N, Bhatia V, Hosoda W, Sawaki A, Hoki K, Hara K, et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol. 2009;44:742-50.
21. Horwhat JD, Paulson EK, McGrath K, Branch MS, Baillie J, Tyler D, et al. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions. Gastrointest Endosc. 2006;63:966-75. (Pubitemid 43776157)
22. Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626-31. (Pubitemid 44288525)
23. Hua YP, Liang LJ, Peng BG, Li SQ, Huang JF. Pancreatic head carcinoma: clinical analysis of 189 cases. Hepatobiliary Pancreat Dis Int. 2009;8:79-84.
24. Japan Pancreas Society. Classification of pancreatic carcinoma. 6th ed. Tokyo: Kanahara & Co.; 2009.
25. Ichikawa T, Sou H, Araki T, Arbab AS, Yoshikawa T, Ishigame K, et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology. 2001;221:107-16. (Pubitemid 32880377)
26. Takahashi N, Fletcher JG, Fidler JL, Hough DM, Kawashima A, Chari ST. Dual-phase CT of autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol. 2008;190:280-6. (Pubitemid 351196595)
27. Kawamoto S, Siegelman SS, Hruban RH, Fishman EK. Lymphoplasmacytic sclerosing pancreatitis (autoimmune pancreatitis): evaluation with multidetector CT. Radiographics. 2008;28:157-70.
28. Edge MD, Hoteit M, Patel AP, Wang X, Baumgarten DA, Cai Q. Clinical significance of main pancreatic duct dilation on computed tomography: single and double duct dilation. World J Gastroenterol. 2007;13:1701-5. (Pubitemid 46711341)
29. Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Tkahashi N, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102:1646-53. (Pubitemid 47206688)
30. Raina A, Krasinskas AM, Greer JB, Lamb J, Fink E, Moser AJ, et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med. 2008;132:48-53.
31. Aalberse RC, Van Milligen F, Tan KY, Stapel SO. Allergenspecific IgG4 in atopic disease. Allergy. 1993;48:559-69.
32. Hussain R, Poindexter RW, Ottesen EA. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J Immunol. 1992;148:2731-7.
33. Shirakata Y, Shiraishi S, Sayama K, Miki Y. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. J Dermatol. 1990;17:661-6.
34. Wakabayashi T, Kawaura Y, Satomura Y, Watanabe H, Motoo Y, Okai T, et al. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol. 2003;98:2679-87. (Pubitemid 38020108)
35. Kim JK, Altun E, Elias J Jr, Pamuklar E, Rivero H, Semelka RC. Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradientecho MRI. J Magn Reson Imaging. 2007;26:313-22. (Pubitemid 47257729)
36. Fujinaga Y, Kadoya M, Hamano H, Kawa S, Momose M, Kawakami S, et al. Radiologic findings of IgG4-related disease. Curr Immunol Rev. 2011;7:186-203.
37. Chandan VS, Iacobuzio-Donahue C, Abraham SC. Patchy distribution of pathologic abnormalities in autoimmune pancreatitis: implications for preoperative diagnosis. Am J Surg Pathol. 2008;32:1762-9.
38. Mitchell DG, Vinitski S, Saponaro S, Tasciyan T, Burk DL Jr, Rifkin MD. Liver and pancreas: improved spin-echo T1 contrast by shorter echo time and fat suppression at 1.5 T. Radiology. 1991;178:67-71.
39. Gabata T, Matsui O, Kadoya M, Yoshikawa J, Miyayama S, Takashima T, et al. Small pancreatic adenocarcinomas: efficacy of MR imaging with fat suppression and gadolinium enhancement. Radiology. 1994;193:683-8. (Pubitemid 24366935)
40. Mergo PJ, Helmberger TK, Buetow PC, Helmberger RC, Ros PR. Pancreatic neoplasms: MR imaging and pathologic correlation. Radiographics. 1997;17:281-301. (Pubitemid 127465057)
41. Nishiharu T, Yamashita Y, Abe Y, Mitsuzaki K, Tsuchigame T, Nakayama Y, et al. Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging-ROC analysis. Radiology. 1999;212:445-52. (Pubitemid 29356565)
42. Obuz F, Dicle O, Coker A, Sagol O, Karademir S. Pancreatic adenocarcinoma: detection and staging with dynamic MR imaging. Eur J Radiol. 2001;38:146-50. (Pubitemid 32396822)
43. Vachiranubhap B, Kim YH, Balci NC, Semelka RC. Magnetic resonance imaging of adenocarcinoma of the pancreas. Top Magn Reson Imaging. 2009;20:3-9.
44. Hattori Y, Gabata T, Zen Y, Mochizuki K, Kitagawa H, Matsui O. Poorly enhanced areas of pancreatic adenocarcinomas on latephase dynamic computed tomography: comparison with pathological findings. Pancreas. 2010;39:1263-70.
45. Okamoto Y, Kawamoto H, Takaki A, Ishida E, Ogawa T, Kuwaki K, et al. Contrast-enhanced ultrasonography depicts small tumor vessels for the evaluation of pancreatic tumors. Eur J Radiol. 2007;61:163-9. (Pubitemid 46038017)
46. Karasawa E, Goldberg HI, Moss AA, Federle MP, London SS. CT pancreatogram in carcinoma of the pancreas and chronic pancreatitis. Radiology. 1983;148:489-93. (Pubitemid 13072795)
47. Tanaka S, Nakaizumi A, Ioka T, Oshikawa O, Uehara H, Nakao M, et al. Main pancreatic duct dilatation: a sign of high risk for pancreatic cancer. Jpn J Clin Oncol. 2002;32:407-11. (Pubitemid 43102777)
48. Gangi S, Fletcher JG, Nathan MA, Christensen JA, Harmsen WS, Crownhart BS, et al. Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. Am J Roentgenol. 2004;182:897-903. (Pubitemid 38391649)
49. Glaser J, Stienecker K. Pancreas and aging: a study using ultrasonography. Gerontology. 2000;46:93-6. (Pubitemid 30103521)